ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668331 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668331; 2) Community: the network communities that were significantly associated with the response to NSC 668331; 3) Molecule: the relationships between components within communities and NSC 668331; 4) MDR: the compounds that were significantly associated with the NSC 668331.

NSC Compound Enrichment Correlation
NSC 125347 Null 0.0420420371076614 0.37518581
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0420420371076614 0.30674149
NSC 143925 Pekilocerin A 0.0420420371076614 0.10269132
NSC 149286 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- 0.0420420371076614 0.33807013
NSC 169774 Bromocriptine methanesulfonate 0.0420420371076614 0.44568979
NSC 254677 Phomazarin 0.0420420371076614 -0.27544184
NSC 290193 CYCLOSPORIN A 0.0420420371076614 0.14638063
NSC 294979 BLEOMYCIN-BAPP 0.0420420371076614 -0.092631693
NSC 295641 Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester 0.0420420371076614 0.65594855
NSC 324368 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.0420420371076614 0.12993211
Total:69  Current:50    [First] [Prev] [Next] [Last]